Hidden Bibliographic Details
| Other authors / contributors: | National Research Council (U.S.). Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation.
|
|---|
| ISBN: | 0309654904
9780309654906
1280310057
9781280310058
9786610310050
661031005X
0309100569
9780309100564
|
|---|
| Digital file characteristics: | text file
|
|---|
| Notes: | Includes bibliographical references.
Restrictions unspecified
Electronic reproduction. [Place of publication not identified] : HathiTrust Digital Library, 2010.
Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. http://purl.oclc.org/DLF/benchrepro0212
English.
digitized 2010 HathiTrust Digital Library committed to preserve
Print version record.
|
|---|
| Summary: | Humans coexist with millions of harmless microorganisms, but emerging diseases, resistance to antibiotics, and the threat of bioterrorism are forcing scientists to look for new ways to confront the microbes that do pose a danger. This report identifies innovative approaches to the development of antimicrobial drugs and vaccines based on a greater understanding of how the human immune system interacts with both good and bad microbes. The report concludes that the development of a single superdrug to fight all infectious agents is unrealistic.
|
|---|
| Other form: | Print version: National Research Council (U.S.). Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials. Treating infectious diseases in a microbial world. Washington, DC : National Academies Press, ©2006 0309100569
|
|---|
